Patents for C07C 59 - Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups oh, o-metal, cho, keto, ether, groups, groups, or groups (14,643) |
---|
09/23/2009 | CN101538268A Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same |
09/23/2009 | CN100542525C Method for the production of solid formulations of sodium 3-hydroxy-3-methylbutyrate |
09/17/2009 | WO2009113586A1 Novel mk8383 analogue and disease control agent for agricultural or horticultural purposes |
09/17/2009 | US20090234005 Protective agent for retinal neuronal cell containing prostaglandin f2alpha derivative as active ingredient |
09/17/2009 | US20090234001 Vitamin d receptor modulators |
09/17/2009 | US20090233880 Equol production accelerating composition |
09/16/2009 | EP2100877A1 4-((Phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
09/16/2009 | EP2100871A1 Catalytic method for preparing lactic acid from renewable raw materials |
09/16/2009 | EP1826195B1 Alpha-ketol unstaurated fatty acid derivatives and plant growth regulators containing the same |
09/16/2009 | EP1542957B1 Process for preparing fluorocarboxylic acids |
09/16/2009 | CN101531587A Zirconium lead tartrate double metal salt, preparation method and application thereof |
09/16/2009 | CN100540522C Method for synthesizing ketoprofen by using ethylbenzene as raw material |
09/15/2009 | US7589234 Fluoroalkyl carboxylic acid derivative, method for producing fluorine-containing polymer, and aqueous dispersion of fluorine-containing polymer |
09/15/2009 | US7589125 2-acetoxy-4-(2,2,3,3,3-pentafluoropropoxy)benzoic acid; methyl 2-hydroxy-4-(2,2,3,3,3-pentafluoropropoxy)benzoate; psoriasis and other immune diseases |
09/15/2009 | US7588790 Process for the removal of undesired flavour and odour components from potassium lactate |
09/11/2009 | WO2009111056A1 Conformationally constrained carboxylic acid derivatives useful for treating metabolic disorders |
09/11/2009 | CA2716352A1 Conformationally constrained carboxylic acid derivatives useful for treating metabolic disorders |
09/10/2009 | US20090227604 Vitamin d receptor modulators |
09/09/2009 | CN101525288A Preparation method of 2, 4-D dimethylamine salt material drug |
09/08/2009 | US7585895 prostaglandin agonists such as 3-(3-{(1R,2S,3R,5R)-5-Chloro-3-hydroxy-2-[4-(1-hydroxy-hexyl)-phenyl]-cyclopentyl}-propyl)-benzoic acid; used for the treatment of vision defects, inflammatory bowel disease and Crohn's disease |
09/08/2009 | US7585856 Resolvins: Biotemplates for novel therapeutic interventions |
09/08/2009 | CA2415620C Method for producing fluorine-containing compound |
09/03/2009 | WO2009107571A1 Method for optical resolution of alkylpiperidin-3-yl carbamate and intermediate therefor |
09/03/2009 | WO2009106810A1 Semiconductor nanoparticle capping agents |
09/03/2009 | US20090221702 Compounds |
09/03/2009 | US20090221654 Prostaglandin e1 and e2 analogs for the treatment of various medical conditions |
09/03/2009 | US20090221527 Tumor necrosis factor inhibitors |
09/03/2009 | CA2716552A1 Semiconductor nanoparticle capping agents |
09/02/2009 | EP2094638A2 2-aryl-2-fluoropropanoic acids and derivatives and pharmaceutical compositions containing them |
08/27/2009 | WO2009103534A2 Elansolids, novel natural metabolites of flexibacter and antibiotically active derivatives thereof |
08/27/2009 | US20090215895 Therapeutic and carrier molecules |
08/27/2009 | US20090214740 Method for the preparation of a stable alkali metal lactate in powder form |
08/26/2009 | EP2093212A1 Elansolids, novel natural metabolites of flexibacter and antibiotically active derivatives thereof |
08/26/2009 | EP2091907A1 Aluminium trilactate powder and method for preparation |
08/26/2009 | EP1506951B9 Method for the preparation of total salvianolic acid |
08/26/2009 | EP1477488B1 Novel optically active compounds, method for kinetic optical resolution of carboxylic acid derivatives and catalysts therefor |
08/26/2009 | CN101514156A Method for recycling naproxen resolution solvent, resolving agent and by-product by overgravitational field |
08/26/2009 | CN101514155A Method for separating and extracting pyruvic acid from fermentation broth by an ion exchange method |
08/26/2009 | CN101514154A Synthetic method for aliphatic alpha-calcium picrolonate |
08/26/2009 | CN101513426A Cinnamylate lipoid substance and application thereof in the preparation of leukotriene A4 hydrolytic enzyme functional regulating medicine |
08/25/2009 | US7579494 Prevention of neutrophil recruitment |
08/25/2009 | US7579426 Heat activated tertiary amine urethane catalysts |
08/25/2009 | US7579375 (2R,7R)-7-Hydroxy-2-propyloctanoic acid, (2R,7S)-7-hydroxy-2-propyloctanoic acid and (2R)-8-hydroxy-2-propyloctanoic acid; treating agent for neurodegenerative diseases such as brain infarction and Alzheimer's disease |
08/20/2009 | WO2009100989A2 Method for producing 6-hydroxy hexanoic acid esters |
08/20/2009 | US20090209649 Alpha-glucosidase inhibitor, inhibitor for blood glucose level elevation and functional food containing tricaffeoylaldaric acid and method for producing tricaffeoylaldaric acid |
08/20/2009 | US20090209588 Novel compounds, their preparation and use |
08/20/2009 | CA2714574A1 Process for preparing 6-hydroxycaproic esters |
08/19/2009 | EP2089350A1 Crystalline potassium salt of lipoxin a4 analogs |
08/19/2009 | CN100528850C Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
08/19/2009 | CN100528828C Production method of racemiation3-hydroxy-3- (2-phenylethyl) hexanoic acid C1-6 alkyl ester |
08/18/2009 | US7576130 Tetramethyltetradecanetetraols as anticarcinogenic, anticholesterol, antidiabetic and hypotensive agents; metabolic disorders, peroxisome proliferator activated receptor associated disorder, Alzheimer's Disease, obesity, pancreatitis; increased HDL levels and lowers LDL levels; combination therapy |
08/13/2009 | WO2009098286A1 Metal lactate powder and method for preparation |
08/12/2009 | CN101506139A Substituted 1,3-diphenylpropane derivatives, preparations and uses thereof |
08/12/2009 | CN101506138A Substituted 1,3-diphenylpropane derivatives, preparations and uses thereof |
08/12/2009 | CN101506136A Perfluorocarboxylic acid salt and process for producing it |
08/12/2009 | CN101503351A Brominated rare-earth carboxylate, as well as preparation and use thereof |
08/12/2009 | CN100526281C Method of synthesizing 3-methoxy-4-dydroxymandelic acid or 3-ethoxy-4-dydroxymandelic acid by acetaldehyde acid method |
08/11/2009 | US7572825 4-(t-Butyldiphenylsiloxy)pentyl-p-toluene sulfonate; 2,2-[4-Biphenyl-5-(t-butyldiphenylsiloxy)pentyl)]-1,3-propanedithiane; osteoporosis, rheumatoid arthritis, cancer associated bone disease, Paget's disease, aseptic loosening of prosthetic implants; inflammation |
08/11/2009 | CA2368688C Novel inhibitors of formation of advanced glycation endproducts (age's) |
08/06/2009 | WO2009097467A2 A functional material and delivery gel composition and method for manufacturing the same |
08/06/2009 | WO2009044251A3 Hydrocortisone derivatives and use thereof for therapeutic or cosmetic indications |
08/05/2009 | EP1940772B1 Novel method for preparing quaternary acid and ammonium salts |
08/05/2009 | EP1583730B1 Novel process for preparing a 5-hydroxy-3-oxo-hexanoic acid derivative |
08/05/2009 | CN101497564A Method for synthesizing aliphatic alcohol polyethenoxy ether carboxylate |
08/05/2009 | CN100522944C Carboxylic acid derivative and thereof |
08/05/2009 | CN100522917C Process of separating acetylpropionic acid with active carbon |
08/05/2009 | CN100522152C Cinnamic acid dimers, their preparation and the use thereof for treating neurodegenerative disease |
08/04/2009 | US7569711 Enone cancer therapeutics |
08/04/2009 | US7569609 Treating Alzheimer's disease with 2-propylpentanoic acid (valproic acid) or salts thereof; improving the GABAA receptor responses |
08/04/2009 | US7569608 Pentanoic acid derivatives |
08/04/2009 | US7569601 Such as (2E)-3-{4-[1-ethyl-2,2-bis(4-hydroxyphenyl)ethenyl]phenyl}-2-propenoic acid; for selective estrogen receptor modulation; menopausal or postmenopausal disorders, vasomotor symptoms, urogenital or vulvar vaginal atrophy, atrophic vaginitis, female sexual dysfunction, breast cancer, osteoporosis |
08/04/2009 | US7569535 11-methyl-13-tridecanolide, 12-methyl-14-tetradecanolide and 13-methyl-15-pentadecanolide, perfume compositions containing the same, and process for production of compounds including the same |
07/30/2009 | WO2009092736A1 Process of separation of glyoxylic acid from an aqueous reaction medium containing glyoxylic acid and hydrochloric acid |
07/30/2009 | WO2009092734A1 Process of preparation of glyoxylic acid aqueous solution |
07/29/2009 | EP2081879A2 Synthesis of isotopically labeled alpha-keto acids and esters |
07/29/2009 | EP1654212B1 Process for separating and recovering 3-hydroxypropionic acid and acrylic acid |
07/29/2009 | EP1093509B1 Fuel lubricity additives |
07/29/2009 | CN101492367A Method for fine purification of lactic acid |
07/28/2009 | US7566803 Vitamin D receptor modulators |
07/28/2009 | US7566795 Preparation of retinyl esters |
07/28/2009 | US7566737 antioxidants and PPAR activators; with rosiglitazone, irbesartan, ezetimibe, simvastatin, Fenofibrate; inflammation, neurodegeneration, cell proliferation; restenosis, atherosclerosis, type 2 diabetes, obesity, hypertension; 1-[2-hydroxy-4-chlorophenyl]-3-[4-carboxydimethylmethyloxyphenyl]prop-2-en-1-one |
07/23/2009 | WO2008076427A3 Naphthalenone compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereof |
07/22/2009 | EP2080751A1 Carboxylic acid derivative |
07/22/2009 | EP2080750A1 Radiation-sensitive composition |
07/22/2009 | EP1667964B1 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
07/22/2009 | CN101486675A 2- and 2,5-substituted phenylketoenols |
07/22/2009 | CN101486639A Novel method for synthesizing mixed glucose derivative |
07/22/2009 | CN100516020C Method of preparing phenoxy alkanoic, alkenoic, and alkynoic acids and salts thereof via a dicarboxylate intermediate |
07/16/2009 | WO2009024707A3 Use of radamea montana extract for preparing a cosmetic composition |
07/16/2009 | WO2007118329A8 Methods and agents for treating tuberculosis |
07/15/2009 | EP1323701B1 Methods for crystallization of hydroxycarboxylic acids |
07/15/2009 | CN100513386C Amide for inhibition of IL-8-induced chemiotaxis of neutrophil leucocytes |
07/15/2009 | CN100513377C Method for separating and extracting abscisic acid from fermented liquid by ionic exchanging and reversed phase chromatography |
07/14/2009 | US7560589 Cycloalkylidene compounds as modulators of estrogen receptor |
07/14/2009 | US7560578 Palm-based hydroxy fatty acid |
07/14/2009 | CA2294615C Recovery of fermentation salts from dilute aqueous solutions |
07/09/2009 | WO2009086277A1 Tetrasubstituted benzenes |
07/09/2009 | WO2009084493A1 Optically active 3-aminopyrrolidine salt, process for production thereof, and method for optical resolution of 3-aminopyrrolidine |
07/09/2009 | US20090176973 Thrombopoietin mimetics |
07/09/2009 | US20090176942 Fluoroethercarboxylic acid and production method thereof, surfactant, method of producing fluoropolymer and aqueous dispersion used thereof |